Ovid Therapeutics Inc (OVID) — Capital Reinvestment Ratio
Latest as of March 2021:
0.00x
Ovid Therapeutics Inc (OVID) has a Capital Reinvestment Ratio of 0.00x as of March 2021, meaning it reinvests 0% of its operating cash flow ($160.90 Million) in capital expenditures ($11.51K). See Ovid Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$160.90 Million
USD
Capital Expenditures
$11.51K
USD
Data as of
Mar 2021
Most recent filing
Ovid Therapeutics Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Ovid Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Ovid Therapeutics Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Ovid Therapeutics Inc from 2021 to 2021. For live market cap and broader valuation context, see Ovid Therapeutics Inc (OVID) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | $118.61 Million | $184.01K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow